NBIX up 55% on Positive results, PGNX has this ..............
It is getting ready for run
NBIX up 55% on Positive results, I just got into PGNX on weakness @ $5.50
1- Topline data release on the chemotherapy experienced cohort of the Phase II PSMA ADC trial will be presented at the American Society of Clinical Oncology's (ASCO) 2014 Genitourinary Cancers Symposium Meeting in San Francisco in January 2014.
2- Progenics Also Announces That Topline Data From a Recently Completed Phase II Trial of 1404 Will be Presented at ASCO GU in January 2014 -- Progenics Pharmaceuticals Announces That Data From a Phase I Study of Its 1404 Imaging Agent Has Been Presented at the Society for Urologic Oncology Meeting -- Progenics' Imaging Agent Correctly Identified the Presence of Primary Prostate Cancer in 100% of Phase I Study Subjects
3- Progenics has scheduled a tentative advisory panel meeting (ADCOM) in March (10th -11th) to review an sNDA for Relistor expanded usage in OIC (opioid induced constipation) chronic pain.